BASEL, Switzerland: The Straumann Group has put its support behind clinician-led clear aligner therapy by acquiring a majority share in Berlin-based DrSmile. Straumann has committed to additional investment in DrSmile and says that, together, the two companies will offer growth opportunities to partner dentists.
After tooth extraction, a series of physiological changes affecting the surrounding alveolar bone take place. This process includes bone formation as well as volumetric resorption, and the latter can compromise implant placement in a prosthetically driven position or the clinical outcome. In an upcoming webinar, which will be broadcast live on 7 July, Drs Susy Linder and Michel Dard will explain the clinical decision-making process after tooth extraction. Prior to the online presentation, the experts answered a few questions for Dental Tribune International on the use of biomaterials in this regard.
In the weeks to come, dental implant manufacturer Straumann will continue to provide dental professionals with free online education opportunities to enhance their implantology skills and learn about exciting concepts. Speakers from the US, Poland and Brazil will present webinars on digital site-specific implant planning, on the Real Arch Sobczak Concept with Straumann Pro Arch, and on new digital trends and technologies which influence the way full-arch treatments are performed today.